Scientists have made a key breakthrough in treating respiratory diseases by developing a new drug delivery system that ...

Tarlatamab improved PFS and OS over chemotherapy as second-line treatment in patients with SCLC in the phase 3 DeLLphi-304 trial.

Novel combination achieves 60.8% response rate and 90.2% disease control rate in first-line non-small cell lung cancer (1L NSCLC) Notably, ~92% of all evaluable patients have PD-L1 TPS <50%, including ...

Imdelltra (tarlatamab-dlle) has shown statistically significant and clinically meaningful improvement in overall survival compared to local standard-of-care chemotherapy among patients with small cell ...

The first patient with small cell lung cancer has been dosed in a trial of peluntamig (PT217) combined with chemotherapy. The first patient has been dosed in the clinical trial of peluntamig (PT217) ...

Lung cancer is the leading cause of cancer deaths among both men and women. Small-cell lung cancer (SCLC) and non-small-cell lung cancer (NSCLC) are the two main types of lung cancer. Most lung ...

Novel therapies targeting molecular pathways, including DLL3 and PARP inhibitors, show promise in improving SCLC survival outcomes. Tarlatamab, a DLL3-targeting bispecific T-cell engager, achieved ...

This year in review of 2024 milestones in non–small cell lung cancer (NSCLC) features coverage of the LAURA trial presented in June at the American Society of Clinical Oncology meeting in ...

Small cell lung cancer (SCLC) accounts for about 15% of lung cancer cases and is categorized into limited and extensive stages. Treatment options include radiation, chemotherapy, and immunotherapy ...

Lung cancer is the most common cause of cancer-related deaths in both men and women, making up about 20% of all cancer deaths. It is mainly divided into two types: non-small cell lung cancer ...

Paraneoplastic syndromes are a group of symptoms that happen in some people who have small-cell lung cancer (SCLC ... Hormones that tumors make, such as ACTH and ADH Analysis of the fluid ...

You may gain weight with small-cell lung cancer due to cancer making your body make ACTH, a hormone that raises the level of cortisol in your body. This makes it easier to retain fluid and you can ...